Unit sales growth for the interventional coronary guidewire market is correlated with the annual PCI procedure volume, and any significant changes will exhibit a direct effect on sales volume. Following multiple clinical studies that presented evidence of over-stenting in the U.S. market, PCI procedure volume and interventional guidewire sales experienced substantial declines for several years. However, procedure fluctuation has recently stabilized, and is expected to grow at low single-digits over the forecast period.
Table of Contents
Executive SummaryU.S. Interventional Cardiology Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
1. RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecasts and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE TREATMENTS AND DIAGNOSTICS
2.2.1 General Diagnostics
2.2.2 Coronary Artery Disease (CAD)
2.2.3 Myocardial Infarction (MI)
2.2.4 Angina Pectoris
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Statistics
INTERVENTIONAL CORONARY GUIDEWIRE MARKET
3.1 INTRODUCTION
3.1.1 Device Construction
3.2 MARKET ANALYSIS AND FORECAST
3.2.1 Interventional Coronary Guidewire Market
3.3 DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE MARKET SHARE ANALYSIS
Abbreviations
Appendix I: Company Press Releases
List of Charts:
Chart 1 1: Interventional Cardiology Device Market by Segment, U.S., 2014 – 2024
Chart 1 2: Interventional Cardiology Device Market Overview, U.S., 2017 & 2024
Chart 3 1: Interventional Coronary Guidewire Market, U.S., 2014 – 2024
Chart 3 2: Leading Competitors, Interventional Coronary Guidewire Market, U.S., 2017
List of Figures:
Figure 1 1: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (1 of 3)
Figure 1 2: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (2 of 3)
Figure 1 3: Interventional Cardiology Device Market Share Ranking by Segment, U.S., 2017 (3 of 3)
Figure 1 4: Companies Researched in this Report, U.S., 2017
Figure 1 5: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (1 of 3)
Figure 1 6: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (2 of 3)
Figure 1 7: Factors Impacting the Interventional Cardiology Market by Segment, U.S. (3 of 3)
Figure 1 8: Recent Events in the Interventional Cardiology Market, U.S., 2014 – 2017
Figure 1 9: Interventional Cardiology Procedures Covered, U.S., 2017
Figure 1 10: Procedure Codes Investigated, U.S., 2017
Figure 1 11: Interventional Cardiology Markets Covered, U.S., 2017 (1 of 2)
Figure 1 12: Interventional Cardiology Markets Covered, U.S., 2017 (2 of 2)
Figure 1 13: Key Report Updates
Figure 1 14: Version History
Figure 3 1: Interventional Coronary Guidewire Market, U.S., 2014 – 2024
Figure 3 2: Drivers and Limiters, Interventional Coronary Guidewire Market, U.S., 2017
Figure 3 3: Leading Competitors, Interventional Coronary Guidewire Market, U.S., 2017
Figure 5 1: Press Release Summary
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Boston Scientific
- Abbott Laboratories
- Medtronic
- Philips
- Terumo
- Cardinal Health
- Merit Medical Systems
- Cook Medical
- Asahi Intecc
- Teleflex
- Cardiovascular Systems Inc.
- Galt Medical
- C.R. Bard
- Angiodynamics
- ACIST Medical Systems
- Infraredx
- Tryton Medical
- B. Braun
- Maquet
Please Note: Not all companies are currently active in every segment or sub-report from this suite.
